Literature DB >> 10468530

Effects of chronic heparin administration on coronary vascular adaptation to hypertension and ventricular hypertrophy in sheep.

M F Flanagan1, T Aoyagi, L W Arnold, C Maute, A M Fujii, J Currier, D Bergau, H B Warren, K Rakusan.   

Abstract

BACKGROUND: Hypertension decreases myocardial perfusion capacity in adults for several reasons, including insufficient coronary angiogenesis with left ventricular (LV) hypertrophy, arteriolar hypertrophy, and altered vasomotion. Heparin influences growth factors that promote angiogenesis and vasodilation and inhibit arteriolar wall thickening. METHODS AND
RESULTS: Adult sheep were given heparin 200 U/kg body wt SC twice daily throughout 6 weeks of LV and coronary hypertension from a progressively constricted ascending aortic band (n=14). They were compared with untreated sheep with (n=13) and without (n=13) aortic stenosis. After 6 weeks, maximum myocardial perfusion was measured during adenosine infusion in the conscious state by the microsphere method. Sheep with aortic stenosis had less maximum coronary flow per gram, less conductance reserve, and thicker arteriolar walls in the LV and nonhypertrophied right ventricle. Capillary density decreased in the LV endomyocardium and remained unchanged in the right ventricle. Heparin-treated sheep had significant partial normalization of coronary conductance reserve and maximum perfusion in both ventricles and capillary density in the LV endomyocardium. Arteriolar wall thickness was unchanged. Compared with untreated sheep with aortic stenosis, in heparin-treated sheep LV FGF-2 protein increased 2-fold, whereas FGF-2 mRNA remained unchanged. VEGF mRNA and protein increased 3-fold and 1.4-fold, respectively, whereas TGF-beta(1) mRNA declined 3-fold.
CONCLUSIONS: Heparin administration during LV hypertension increases heparin-binding angiogenic factors FGF-2 and VEGF in the LV and ameliorates decreases in LV perfusion capacity and capillary density.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10468530     DOI: 10.1161/01.cir.100.9.981

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  5 in total

Review 1.  The effects of anaemia as a programming agent in the fetal heart.

Authors:  L Davis; K L Thornburg; G D Giraud
Journal:  J Physiol       Date:  2005-03-10       Impact factor: 5.182

2.  Up-regulation of soluble vascular endothelial growth factor receptor-1 prevents angiogenesis in hypertrophied myocardium.

Authors:  Elisabeth Kaza; Klemens Ablasser; Dimitrios Poutias; Eric R Griffiths; Fawzy A Saad; Jochen G Hofstaetter; Pedro J del Nido; Ingeborg Friehs
Journal:  Cardiovasc Res       Date:  2010-10-08       Impact factor: 10.787

3.  Hypoxic regulation of VEGF, HIF-1(alpha) in coronary collaterals development.

Authors:  Ki Chul Sung; Kyung Soo Kim; Sang Lee
Journal:  Korean J Intern Med       Date:  2005-12       Impact factor: 2.884

4.  A novel fibroblast growth factor-1 ligand with reduced heparin binding protects the heart against ischemia-reperfusion injury in the presence of heparin co-administration.

Authors:  Chahua Huang; Yang Liu; Andrew Beenken; Lin Jiang; Xiang Gao; Zhifeng Huang; Anna Hsu; Garrett J Gross; Yi-Gang Wang; Moosa Mohammadi; Jo El J Schultz
Journal:  Cardiovasc Res       Date:  2017-11-01       Impact factor: 10.787

5.  Association of myocardial angiogenesis with structural and functional ventricular remodeling in aortic stenosis patients with normal ejection fraction.

Authors:  Seung-Pyo Lee; Hyung-Kwan Kim; Yong-Jin Kim; Seil Oh; Dae-Won Sohn
Journal:  J Cardiovasc Ultrasound       Date:  2014-06-30
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.